Stay updated on Comparing BI 695500 vs. Rituximab in Follicular Lymphoma: Clinical Trial
Sign up to get notified when there's something new on the Comparing BI 695500 vs. Rituximab in Follicular Lymphoma: Clinical Trial page.

Latest updates to the Comparing BI 695500 vs. Rituximab in Follicular Lymphoma: Clinical Trial page
- Check5 days agoChange DetectedA new revision label 'Revision: v3.5.4' was added and the previous 'Revision: v3.5.3' label was removed, signaling a minor frontend update to the page. The change does not affect the study data, eligibility criteria, or results.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page’s footer revision label was updated from v3.5.2 to v3.5.3, reflecting a minor site/version update rather than a change to the clinical trial study information.SummaryDifference0.0%

- Check34 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. No user-visible changes to the Study Details page were observed.SummaryDifference0.0%

- Check63 days agoChange DetectedRevision: v3.5.0 is now shown on the page, replacing the previous v3.4.3. This is a metadata update and does not change study details or user-facing content.SummaryDifference0.0%

- Check70 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check98 days agoChange DetectedAdded the latest site revision banner: Revision: v3.4.2, and removed older notices including the funding lapse notice and Revision: v3.4.1.SummaryDifference0.4%

Stay in the know with updates to Comparing BI 695500 vs. Rituximab in Follicular Lymphoma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing BI 695500 vs. Rituximab in Follicular Lymphoma: Clinical Trial page.